Integrating Multiomics with Longitudinal & Cross-Sectional Clinical Data from AD & PD Patients
Time: 8:30 am
day: Conference Day One
Details:
- Integrating genomic, transcriptomic, metabolomic, and proteomic data from biofluids (plasma, CSF, and urine) and post-mortem brain tissue to determine multimodal signatures
- Performing a deep molecular characterization of genetically defined populations to identify potential novel biomarkers
- Identifying molecularly-defined clusters of patients with distinctive disease progression and clinical features using multi-omics approaches
